200 related articles for article (PubMed ID: 36696221)
1. Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice.
Maroney SA; Siebert AE; Martinez ND; Rasmussen M; Peterson JA; Weiler H; Lincoln J; Mast AE
J Thromb Haemost; 2023 Mar; 21(3):639-651. PubMed ID: 36696221
[TBL] [Abstract][Full Text] [Related]
2. A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development.
Ellery PE; Maroney SA; Cooley BC; Luyendyk JP; Zogg M; Weiler H; Mast AE
Blood; 2015 Jun; 125(26):4078-84. PubMed ID: 25954015
[TBL] [Abstract][Full Text] [Related]
3. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
4. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
[TBL] [Abstract][Full Text] [Related]
6. The contribution of TFPIα to the hemostatic response to injury in mice.
Marar TT; Martinez ND; Maroney SA; Siebert AE; Wu J; Stalker TJ; Tomaiuolo M; Delacroix S; Simari RD; Mast AE; Brass LF
J Thromb Haemost; 2021 Sep; 19(9):2182-2192. PubMed ID: 34160126
[TBL] [Abstract][Full Text] [Related]
7. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
9. Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.
Wood JP; Baumann Kreuziger LM; Ellery PER; Maroney SA; Mast AE
Blood Adv; 2017 Feb; 1(6):386-395. PubMed ID: 28580443
[TBL] [Abstract][Full Text] [Related]
10. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
[TBL] [Abstract][Full Text] [Related]
11. Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.
Hamilton JR; Cornelissen I; Coughlin SR
J Thromb Haemost; 2004 Aug; 2(8):1429-35. PubMed ID: 15304051
[TBL] [Abstract][Full Text] [Related]
12. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.
Maroney SA; Haberichter SL; Friese P; Collins ML; Ferrel JP; Dale GL; Mast AE
Blood; 2007 Mar; 109(5):1931-7. PubMed ID: 17082321
[TBL] [Abstract][Full Text] [Related]
13. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
[TBL] [Abstract][Full Text] [Related]
14. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
Mast AE; Broze GJ
Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Tissue Factor Pathway Inhibitor Isoform Beta or Gamma, but not Alpha, Improves Clotting in Hemophilia Mice.
Eldem I; Heck LA; Subramanian R; Lasky NM; Ashworth K; Di Paola J; Girard TJ
J Thromb Haemost; 2024 Jun; ():. PubMed ID: 38925489
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.
Miyazawa K; Fogelson AL; Leiderman K
Biophys J; 2023 Jan; 122(1):99-113. PubMed ID: 36403087
[TBL] [Abstract][Full Text] [Related]
17. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
[TBL] [Abstract][Full Text] [Related]
18. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid- and late-gestation by platelet TFPIα overexpression.
Siebert AE; Maroney SA; Martinez ND; Mast AE
J Thromb Haemost; 2021 Jun; 19(6):1483-1492. PubMed ID: 33728763
[TBL] [Abstract][Full Text] [Related]
20. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
Maroney SA; Mast AE
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
